Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;59(6):102995.
doi: 10.1016/j.transci.2020.102995. Epub 2020 Nov 5.

A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma

Behzad Einollahi  1 , Luca Cegolon  2 , Hassan Abolghasemi  3 , Sina Imanizadeh  4 , Ali Bahramifar  5 , Shi Zhao  6 , Ramezan Jafari  7 , Mohammad Javanbakht  8
Affiliations
Case Reports

A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma

Behzad Einollahi et al. Transfus Apher Sci. 2020 Dec.

Abstract

We present a critically ill patient affected by COVID-19, whose chest computed tomography (CT) scan featured lung consolidations and severe patchy ground-glass opacitie. On day 3 since hospital admission the patient was placed on convalescent plasma treatment. A combined treatment with supportive care, hemoperfusion and convalescent plasma successfully managed to save the patient's life. Convalescent plasma probably contributed to heal this patient and should always be considered in the management of critically ill COVID-19 cases.

Keywords: COVID-19; Convalescent plasma; Critical; PCR.

PubMed Disclaimer

Conflict of interest statement

The authors report no declarations of interest.

Figures

Fig. 1
Fig. 1
Axial chest CT scan without contrast of patient affected by COVID-19 pneumonia. (A, B, C): Bilateral severe ground glass opacities superimposed with bilateral consolidative and linear opacities. (D, E, F): Normal lung parenchyma with a very faint residual of ground glass opacities in both lungs field, compatible with a dramatic follow-up response at 4 months since treatment with convalescent plasma.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Karataş A., İnkaya A.Ç, Demiroğlu H. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma [published online ahead of print, 2020 Jul 3] Transfus Apher Sci. 2020 - PMC - PubMed
    1. Çınar O.E., Sayınalp B., Aladağ Karakulak E. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis [published online ahead of print, 2020 May 29] Transfus Apher Sci. 2020;102821 - PMC - PubMed
    1. Marano G., Vaglio S., Pupella S. Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus. 2016;14:152–157. - PMC - PubMed
    1. Zhang L., Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92:479–490. - PMC - PubMed
    1. Cegolon L., Pichierri J., Mastrangelo G., Cinquetti S., Sotgiu G., Bellizzi S. Hypothesis to explain the severe form of COVID-19 in Northern Italy. BMJ Glob Health. 2020;5(6) - PMC - PubMed

Publication types